MarketCap
Facebook
X
TelegramAnnual report 2024
added 02-14-2026
Sanofi EV/EBITDA Ratio 2011-2026 | SNY
Annual EV/EBITDA Ratio Sanofi
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 7.71 | 13.2 | 14.6 | 14.8 | 13 | 12.1 | 12.5 | 13.8 | 14.8 | 12.4 | 10.4 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.8 | 7.71 | 12.7 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.591 | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
1.84 | - | 1052.0 % | $ 415 M |  USA |
 |
Acasti Pharma
ACST
|
1.8 | - | 4.01 % | $ 150 M |  Canada |
 |
Adverum Biotechnologies
ADVM
|
-1.32 | - | - | $ 86.2 M | USA |
 |
AgeX Therapeutics
AGE
|
-1.85 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.27 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
I-Mab
IMAB
|
595 | - | - | $ 866 M |  China |
 |
Aptorum Group Limited
APM
|
29.4 | $ 0.81 | 0.15 % | $ 4.42 M | China |
 |
argenx SE
ARGX
|
-39.4 | $ 836.39 | -0.46 % | $ 25 B |  Niderland |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Akero Therapeutics
AKRO
|
-4.64 | - | - | $ 3.67 B | USA |
 |
Ascendis Pharma A/S
ASND
|
-15.7 | $ 234.52 | -0.2 % | $ 5 B |  Danmark |
 |
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
-3.38 | - | -0.23 % | $ 916 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-0.994 | $ 3.44 | 3.42 % | $ 8.28 B |  Australia |
 |
Allena Pharmaceuticals
ALNA
|
0.298 | - | 3.16 % | $ 1.9 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
AlloVir
ALVR
|
-3.61 | - | 4.14 % | $ 49.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.796 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Akouos
AKUS
|
-1.13 | - | 0.23 % | $ 488 M | USA |
 |
BioVie
BIVI
|
-0.244 | $ 1.24 | -0.8 % | $ 1.83 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-20.4 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
-1.19 | - | - | $ 10.1 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
671 | $ 61.58 | -1.66 % | $ 11.7 B | USA |
 |
Acorda Therapeutics
ACOR
|
0.777 | - | -24.86 % | $ 820 K | USA |
 |
Atea Pharmaceuticals
AVIR
|
-0.282 | $ 4.56 | -1.94 % | $ 384 M | USA |
 |
Acer Therapeutics
ACER
|
-3.39 | - | 2.71 % | $ 14 M | USA |
 |
Aravive
ARAV
|
-0.158 | - | -13.39 % | $ 1.45 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14 | - | - | - |  Russia |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.546 | - | - | $ 26.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.871 | - | -52.27 % | $ 4.45 M | USA |
 |
Capricor Therapeutics
CAPR
|
-2.14 | $ 28.24 | 1.18 % | $ 756 M | USA |
 |
Axsome Therapeutics
AXSM
|
-8.03 | $ 165.14 | -2.83 % | $ 8.22 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.785 | - | - | $ 7.46 M |  Israel |
 |
CASI Pharmaceuticals
CASI
|
-26.1 | $ 0.31 | -61.59 % | $ 42.2 M | USA |
 |
Atreca
BCEL
|
-2.76 | - | -11.76 % | $ 5.79 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-5.5 | - | - | $ 2.17 B | USA |
 |
BioDelivery Sciences International
BDSI
|
8 | - | -4.8 % | $ 255 M | USA |
 |
Catalyst Biosciences
CBIO
|
0.34 | $ 12.21 | -3.48 % | $ 804 M | USA |
 |
Aeterna Zentaris
AEZS
|
4.4 | - | 5.93 % | $ 314 M | Canada |
 |
BeiGene, Ltd.
BGNE
|
-208 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biogen
BIIB
|
12.7 | $ 191.78 | -1.72 % | $ 28.1 B | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
1.13 | - | -9.72 % | $ 5.89 M | USA |
 |
Baudax Bio
BXRX
|
-1.99 | - | 0.59 % | $ 63 K | USA |
 |
Aptose Biosciences
APTO
|
388 | - | -45.71 % | $ 1.2 M | Canada |
 |
Aptinyx
APTX
|
-1.56 | - | -39.0 % | $ 4.57 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-0.807 | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
4.1 | $ 110.5 | -0.35 % | $ 27.2 B | Germany |
 |
Amneal Pharmaceuticals
AMRX
|
1.63 | $ 14.64 | -0.17 % | $ 4.52 B | USA |